Adam Scott Levy, CFO and Secretary at Mineralys Therapeutics, Inc. (MLYS), sold 95,049 shares at $14.70 ($1.4M) on 2025-07-30, disclosed to the SEC on 2025-07-30.
Open-market sale of $1.4M MLYS by CFO and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.04 | 12,946 | $182K | 13.1% |
| 2 | $14.04 | 12,946 | $182K | 13.1% |
| 3 | $14.00 | 807 | $11K | 0.8% |
| 4 | $14.70 | 51,500 | $757K | 54.6% |
| 5 | $15.10 | 8,425 | $127K | 9.2% |
| 6 | $15.10 | 8,425 |
| $127K |
| 9.2% |
| Total | $14.59 avg | 95,049 | $1.4M | 100% |
| Filing → |
| MLYS | SELL | 2025-10-15 | $904K | — | Filing → |
| MLYS | SELL | 2025-07-15 | $311K | — | Filing → |
| MLYS | SELL | 2025-04-15 | $259K | — | Filing → |